Board WCoTE (2019) Breast tumours , WHO classification of tumors, 5nd edn. World Health Organization, Geneva, pp 1–28

Rosen LE, Gattuso P (2017) Neuroendocrine tumors of the breast. Arch Pathol Lab Med 141(11):1577–1581. https://doi.org/10.5858/arpa.2016-0364-RS

Article  CAS  PubMed  Google Scholar 

Sun H, Dai S, Xu J, Liu L, Yu J, Sun T (2022) Primary neuroendocrine tumor of the breast: current understanding and future perspectives. Front Oncol 12:848485. https://doi.org/10.3389/fonc.2022.848485

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsang JY, Tse GM (2021) Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classification. Modern PathoL 34:1062–1073

Article  Google Scholar 

Ozaki Y, Miura S, Oki R, Morikawa T, Uchino K (2021) Neuroendocrine neoplasms of the breast: the latest WHO classification and review of the literature. Cancers (Basel) 14(1):196. https://doi.org/10.3390/cancers14010196

Article  CAS  PubMed  Google Scholar 

Ellis IO, Schnitt SJ, Sastre-Garau X et al (2003) Tumors of the breast, neuroendocrine tumours. In: Tavassooli FA, Devilee P et al (eds) World Health Organization Classification of tumours, pathology and genetics of tumours of the breast and female genital organs. IARC, Lyon, p 3264

Google Scholar 

Robens J, Goldstein L, Gown AM, Schnitt SJ (2010) Thyroid transcription factor-1 expression in breast carcinomas. Am J Surg Pathol 34(12):1881–1885. https://doi.org/10.1097/PAS.0b013e3181f884e8

Article  PubMed  Google Scholar 

Christie M, Chin-Lenn L, Watts MM, Tsui AE, Buchanan MR (2010) Primary small cell carcinoma of the breast with TTF-1 and neuroendocrine marker expressing carcinoma in situ. Int J Clin Exp Pathol 3(6):629–633

PubMed  PubMed Central  Google Scholar 

Wang J, Wei B, Albarracin CT, Hu J, Abraham SC, Wu Y (2014) Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database. BMC Cancer 14:147. https://doi.org/10.1186/1471-2407-14-147

Article  PubMed  PubMed Central  Google Scholar 

Shin SJ, DeLellis RA, Ying L, Rosen PP (2000) Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol 24:1231–1238. https://doi.org/10.1097/00000478-200009000-00006

Article  CAS  PubMed  Google Scholar 

Hare F, Giri S, Patel JK, Hahn A, Martin MG (2015) A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy. Springerplus 4:138. https://doi.org/10.1186/s40064-015-0913-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong YNS, Jack RH, Mak V, Henrik M, Davies EA (2009) The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970–2004. BMC Cancer 9:209. https://doi.org/10.1186/1471-2407-9-209

Article  PubMed  PubMed Central  Google Scholar 

Wei B, Ding T, Xing Y et al (2010) Invasive neuroendocrine carcinoma of the breast: a distinct subtype of aggressive mammary carcinoma. Cancer 116(19):4463–4473

Article  PubMed  Google Scholar 

Cloyd JM, Yang RL, Allison KH, Norton JA, Hernandez-Boussard T, Wapnir IL (2014) Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast. Breast Cancer Res Treat 148(1):637–664

Article  CAS  PubMed  Google Scholar 

Zhang Y, Chen Z, Bao Y et al (2013) Invasive euroendocrine carcinoma of the breast: a prognostic research of 107 Chinese patients. Neoplasma 60(2):215–222

Article  CAS  PubMed  Google Scholar 

Park WM, Wu Y, Wei W, Yang WT (2014) Primary neuroendocrine carcinoma of the breast: clinical, imaging and histologic features. AJR Am J Roentgenol 203(2):W221–W230

Article  PubMed  Google Scholar 

Ogawa H, Nishio A, Satake H, Naganawa S, Imai T, Sawaki M, Yamamoto E, Miyata T (2008) Neuroendocrine tumor in the breast. Radiat Med 26:28–32. https://doi.org/10.1007/s11604-007-0182-y

Article  PubMed  Google Scholar 

Gallo M, Campione S, Di Vito V, Fortunati N, Calzo FL, Messina E, Ruggeri RM, Faggiano A, Colao AAL (2020) Primary neuroendocrine neoplasms of the breast: still open issues. Front Endocrinol 11. https://doi.org/10.3389/fendo.2020.610230

Arslan E, Çermik TF, Trabulus FDC, Talu ECK, Başaran Ş (2019) Diagnostic impact of 18F-FDG PET/CT on the management of rare breast carcinomas: apocrine and neuroendocrine carcinomas. Rev Esp Med Nucl Imagen Mol 38:147–153. https://doi.org/10.1016/j.remnie.2018.11.009

Article  CAS  PubMed  Google Scholar 

Trabelsi A, Benabdelkrim S, Stita W, Gharbi O, Jaidane L, Hmissa S et al (2008) Carcinome neuroendocrine primitif du sein. Imagerie de la Femme 18(3):184–186. https://doi.org/10.1016/S1776-9817(08)77197-9

Article  Google Scholar 

Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL (2022) Overview of the 2022 WHO Classification of neuroendocrine neoplasms. Endocr Pathol 33:115–154. https://doi.org/10.1007/s12022-022-09708-2

Article  CAS  PubMed  Google Scholar 

Metovic J, Castellano I, Marinelli E, Osella-Abate S, Sapino A, Cassoni P, Papotti M (2021) INSM1 expression in breast neoplasms with neuroedocrine features. Endocr Pathol 32:452–460. https://doi.org/10.1007/s12022-021-09682-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krawczyk N, Röwer R, Anlauf M, Muntanjohl C, Baldus SE, Neumann M, Banys-Paluchowski M, Otten S, Luczak K, Ruckhäberle E, Mohrmann S, Hoffmann J, Kaleta T, Jaeger B, Esposito I, Fehm T (2022) Invasive breast carcinoma with neuroendocrine differentiation: a single-center analysis of clinical features and prognosis. Geburtshilfe Frauenheilkd 82:68–84

Article  CAS  PubMed  Google Scholar 

Papotti M, Macrì L, Finzi G, Capella C, Eusebi V, Bussolati G (1989) Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases. Semin Diagn Pathol 6:174–188

CAS  PubMed  Google Scholar 

Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Zhang H, Sahin A, Chen J et al (2011) Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology 59:106–115. https://doi.org/10.1111/j.1365-2559.2011.03880.x

Article  PubMed  Google Scholar 

Maluf H, Koerner F (1994) Carcinomas of the breast with endocrine differentiation: a review. Virchows Arch 425:449–457. https://doi.org/10.1007/BF00197547

Article  CAS  PubMed  Google Scholar 

Talu CK, Leblebici C, Ozturk TK, Hacihasanoglu E, Koca SB, Gucin Z (2018) Primary breast carcinomas with neuroendocrine features: clinicopathological features and analysis of tumor growth patterns in 36 cases. Ann Diagn Pathol 34:122–130. https://doi.org/10.1016/j.anndiagpath.2018.03.010

Article  Google Scholar 

Seijnhaeve E, Galant C, Van Bockstal MR (2021) Nuclear insulinoma-associated protein 1 expression as a marker of neuroendocrine differentiation in neoplasms of the breast. Int J Surg Pathol 29:496–502. https://doi.org/10.1177/1066896920985938

Article  CAS  PubMed  Google Scholar 

Rakha EA, Reis-Filho JS, Sasano H, Wu Y (2019) Neuroendocrine neoplasms: introduction, neuroendocrine tumor, neuroendocrine carcinoma. WHO Classification of Tumours Editorial Board. Breast tumours, 5th edn. International Agency for Research on Cancer, Lyon, France, pp 155–161

Google Scholar 

Papotti M, Macri L, Bussolati G (1989) Correlative study on neuro-endocrine differentiation and presence of somatostatin receptors in breast carcinomas. Int J Cancer 43:365–369

Article  CAS  PubMed  Google Scholar 

Nonaka D, Tang Y, Chiriboga L et al (2008) Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol 21:192–200. https://doi.org/10.1038/modpathol.3801002

Article  CAS  PubMed  Google Scholar 

Kumar U, Grigorakis SI, Watt HL (2005) Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathology. Breast Cancer Res Treat 92:175–186

Article  CAS  PubMed